Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to look at how elderly women (70 years of age or older)
with newly diagnosed ovarian, peritoneal, or fallopian tube cancer manage six cycles of
carboplatin and paclitaxel, what side effects they experience, and how their cancer reacts or
responds to standard carboplatin and paclitaxel chemotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital